Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669027 | SCV000793723 | uncertain significance | Tay-Sachs disease | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000669027 | SCV001017051 | likely benign | Tay-Sachs disease | 2022-09-15 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811437 | SCV002049721 | uncertain significance | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | The HEXA c.1146+18A>G variant (rs1555472543) is reported in the literature in the heterozygous state in individuals with enzyme levels consistent with carrier status for Tay-Sachs disease (Martin 2007, Triggs-Raine 1995). This variant is also reported in ClinVar (Variation ID: 553551), but is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This is an intronic variant in a weakly conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant does not alter splicing. However, given the lack of clinical and functional data, the significance of the c.1146+18A>G variant is uncertain at this time. References: Martin DC et al. Evaluation of the risk for Tay-Sachs disease in individuals of French Canadian ancestry living in new England. Clin Chem. 2007 Mar;53(3):392-8. Triggs-Raine B et al. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England. Am J Hum Genet. 1995 Apr;56(4):870-9. |